All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Canadian Drug Access Pathway
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (732 days) for Canadian…
Letter to The Honourable Jean-Yves Duclos, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process….
Letter to The Hon. Chrystia Freeland, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process. *Cette lettre est disponible en anglais seulement….
Letter to The Honourable Mary Ng, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process. *Cette lettre est disponible en anglais seulement….
Ministerial PMPRB Guideline Letter to The Hon. François-Philippe Champagne, P.C., M.P.
IMC calls for a suspension of the Patented Medicine Prices Review Board’s (PMPRB) guidelines consultation process….
pCPA overview of the Negotiation Process
Learn more about the negotiation process from the pCPA….
